Nadim Ahmed - 23 Mar 2023 Form 4 Insider Report for Cullinan Oncology, Inc. (CGEM)

Role
President and CEO, Director
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
Issuer symbol
CGEM
Transactions as of
23 Mar 2023
Transactions value $
-$7,420
Form type
4
Filing time
27 Mar 2023, 16:05:10
Previous filing
23 Feb 2023
Next filing
26 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGEM Common Stock Sale -$7.42K -706 -0.59% $10.51 118K 23 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Remarks:

Exhibit 24.1 - Power of Attorney